U.S. Biosimulation Market (2025 - 2030) Size, Share & Trends Analysis Report By Offering (Software, Services), By Application, By Therapeutic Area, By Deployment Model, By Pricing Model, By End-use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Segment Definitions
                    1.2. Estimates and Forecast Timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased Database
                        1.4.2. GVR’s Internal Database
                        1.4.3. Secondary Sources
                        1.4.4. Primary Research
                        1.4.5. Details of Primary Research
                        1.4.6. Research Assumption
                    1.5. Information or Data Analysis
                        1.5.1. Data Analysis Models
                    1.6. Market Formulation & Data Visualization
                    1.7. Model Details
                        1.7.1. Commodity Flow Analysis
                    1.8. Objectives
                        1.8.1. Objective - 1
                        1.8.2. Objective - 2
                        1.8.3. Objective - 3
                    1.9. List of Secondary Sources
                    1.10. List of Secondary Sources
Chapter 2. Executive Summary
                    2.1. U.S. Biosimulation Market
                        2.1.1. Market Snapshot
                        2.1.2. Segment Snapshot
                            2.1.2.1. Offering segment outlook
                            2.1.2.2. Application segment outlook
                            2.1.2.3. Therapeutic Area segment outlook
                            2.1.2.4. Deployment Model segment outlook
                            2.1.2.5. Pricing Model segment outlook
                            2.1.2.6. End Use segment outlook
                        2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Trends and Outlook
                    3.3. Market Dynamics
                        3.3.1. Market Driver Analysis
                            3.3.1.1. Rising prevalence of chronic diseases
                            3.3.1.2. Growing demand for personalized medicine
                            3.3.1.3. Technological advancements
                        3.3.2. Market Restraint Analysis
                            3.3.2.1. High cost associated with biosimulation technology and software
                            3.3.2.2. Stringent regulatory requirements
                        3.3.3. Market Opportunity Analysis
                        3.3.4. Market Challenges Analysis
                    3.4. U.S. Biosimulation Market Analysis Tools: PESTEL
                        3.4.1. Political & Legal
                        3.4.2. Economic & Social
                        3.4.3. Technology
                        3.4.4. Environmental
                        3.4.5. Social
                    3.5. Technology Trends
                    3.6. Case Studies & Insights
                    3.7. U.S. Biosimulation Market Analysis Tools: Porter's
                    3.8. Covid-19 Impact Analysis
Chapter 4. U.S. Biosimulation Market: Offering Estimates & Trend Analysis
                    4.1. U.S. Biosimulation Market: Offering Movement Analysis
                    4.2. U.S. Biosimulation Market: Offering Segment Dashboard
                    4.3. Offering Movement & Market Share Analysis, 2024 & 2030
                    4.4. U.S. Biosimulation Market Estimates & Forecast, by Offering
                    4.5. Software
                        4.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                        4.5.2. Molecular Modeling & Simulation Software
                            4.5.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                        4.5.3. Clinical Trial Design Software
                            4.5.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                        4.5.4. PK/PD Modeling and Simulation Software
                            4.5.4.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                        4.5.5. Pbpk Modeling and Simulation Software
                            4.5.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                        4.5.6. Toxicity Prediction Software
                            4.5.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                        4.5.7. Other Software
                            4.5.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    4.6. Services
                        4.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                        4.6.2. Contract Services
                            4.6.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                        4.6.3. Consulting
                            4.6.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                        4.6.4. Other (Implementation, Training, & Support)
                            4.6.4.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
Chapter 5. U.S. Biosimulation Market: Application Estimates & Trend Analysis
                    5.1. U.S. Biosimulation Market: Application Movement Analysis
                    5.2. U.S. Biosimulation Market: Application Segment Dashboard
                    5.3. Application Movement & Market Share Analysis, 2024 & 2030
                    5.4. U.S. Biosimulation Market Estimates & Forecast, by Application
                    5.5. Drug Discovery & Development
                        5.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    5.6. Disease Modeling
                        5.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    5.7. Other (Precision Medicine, Toxicology)
                        5.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
Chapter 6. U.S. Biosimulation Market: Therapeutic Area Estimates & Trend Analysis
                    6.1. U.S. Biosimulation Market: Therapeutic Area Movement Analysis
                    6.2. U.S. Biosimulation Market: Therapeutic Area Segment Dashboard
                    6.3. Therapeutic Area Movement & Market Share Analysis, 2024 & 2030
                    6.4. U.S. Biosimulation Market Estimates & Forecast, by Therapeutic Area
                    6.5. Oncology
                        6.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    6.6. Cardiovascular Disease
                        6.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    6.7. Infectious Disease
                        6.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    6.8. Neurological Disorders
                        6.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    6.9. Others
                        6.9.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
Chapter 7. U.S. Biosimulation Market: Deployment Model Estimates & Trend Analysis
                    7.1. U.S. Biosimulation Market: Deployment Model Movement Analysis
                    7.2. U.S. Biosimulation Market: Deployment Model Segment Dashboard
                    7.3. Deployment Model Movement & Market Share Analysis, 2024 & 2030
                    7.4. U.S. Biosimulation Market Estimates & Forecast, by Deployment Model
                    7.5. Cloud-based
                        7.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    7.6. On-premise
                        7.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    7.7. Hybrid Model
                        7.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
Chapter 8. U.S. Biosimulation Market: Pricing Model Estimates & Trend Analysis
                    8.1. U.S. Biosimulation Market: Pricing Model Movement Analysis
                    8.2. U.S. Biosimulation Market: Pricing Model Segment Dashboard
                    8.3. Pricing Model Movement & Market Share Analysis, 2024 & 2030
                    8.4. U.S. Biosimulation Market Estimates & Forecast, by Pricing Model
                    8.5. License-based Model
                        8.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    8.6. Subscription-based Model
                        8.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    8.7. Service-based Model
                        8.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    8.8. Pay Per Use Model
                        8.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
Chapter 9. U.S. Biosimulation Market: End Use Estimates & Trend Analysis
                    9.1. U.S. Biosimulation Market: End Use Movement Analysis
                    9.2. U.S. Biosimulation Market: End Use Segment Dashboard
                    9.3. End Use Movement & Market Share Analysis, 2024 & 2030
                    9.4. U.S. Biosimulation Market Estimates & Forecast, by End Use
                    9.5. Life Sciences Companies
                        9.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    9.6. Academic Research Institutions
                    9.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
                    9.7. Others (CROs/CDMOs, Regulatory Authorities)
                        9.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
                    10.1. Company Categorization
                    10.2. Company Market Position/Share Analysis, 2024
                    10.3. Company Share Analysis
                    10.4. Company Profiles/Listing
                        10.4.1. Certara, USA.
                            10.4.1.1. Participant’s Overview
                            10.4.1.2. Financial Performance
                            10.4.1.3. Product Benchmarking
                            10.4.1.4. Recent Developments
                        10.4.2. Dassault Systèmes
                            10.4.2.1. Participant’s Overview
                            10.4.2.2. Financial Performance
                            10.4.2.3. Product Benchmarking
                            10.4.2.4. Recent Developments
                        10.4.3. Advanced Chemistry Development
                            10.4.3.1. Participant’s Overview
                            10.4.3.2. Financial Performance
                            10.4.3.3. Product Benchmarking
                            10.4.3.4. Recent Developments
                        10.4.4. Simulation Plus
                            10.4.4.1. Participant’s Overview
                            10.4.4.2. Financial Performance
                            10.4.4.3. Product Benchmarking
                            10.4.4.4. Recent Developments
                        10.4.5. Schrodinger, Inc.
                            10.4.5.1. Participant’s Overview
                            10.4.5.2. Financial Performance
                            10.4.5.3. Product Benchmarking
                            10.4.5.4. Recent Developments
                        10.4.6. Chemical Computing Group ULC
                            10.4.6.1. Participant’s Overview
                            10.4.6.2. Financial Performance
                            10.4.6.3. Product Benchmarking
                            10.4.6.4. Recent Developments
                        10.4.7. Physiomics Plc
                            10.4.7.1. Participant’s Overview
                            10.4.7.2. Financial Performance
                            10.4.7.3. Product Benchmarking
                            10.4.7.4. Recent Developments
                        10.4.8. Rosa & Co. LLC
                            10.4.8.1. Participant’s Overview
                            10.4.8.2. Financial Performance
                            10.4.8.3. Product Benchmarking
                            10.4.8.4. Recent Developments
                        10.4.9. BioSimulation Consulting Inc.
                            10.4.9.1. Participant’s Overview
                            10.4.9.2. Financial Performance
                            10.4.9.3. Product Benchmarking
                            10.4.9.4. Recent Developments
                        10.4.10. Genedata AG
                            10.4.10.1. Participant’s Overview
                            10.4.10.2. Financial Performance
                            10.4.10.3. Product Benchmarking
                            10.4.10.4. Recent Developments
                        10.4.11. Instem Group of Companies
                            10.4.11.1. Participant’s Overview
                            10.4.11.2. Financial Performance
                            10.4.11.3. Product Benchmarking
                            10.4.11.4. Recent Developments
                        10.4.12. PPD, Inc.
                            10.4.12.1. Participant’s Overview
                            10.4.12.2. Financial Performance
                            10.4.12.3. Product Benchmarking
                            10.4.12.4. Recent Developments
                        10.4.13. Yokogawa Insilico Biotechnology GmbH
                            10.4.13.1. Participant’s Overview
                            10.4.13.2. Financial Performance
                            10.4.13.3. Product Benchmarking
                            10.4.13.4. Recent Developments

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. biosimulation market revenue estimates and forecast, by offering, 2018 - 2030 (USD Million)
Table 4 U.S. biosimulation market revenue estimates and forecast, by application, 2018 - 2030 (USD Million)
Table 5 U.S. biosimulation market revenue estimates and forecast, by therapeutic area, 2018 - 2030 (USD Million)
Table 6 U.S. biosimulation market revenue estimates and forecast, by deployment model, 2018 - 2030 (USD Million)
Table 7 U.S. biosimulation market revenue estimates and forecast, by pricing model, 2018 - 2030 (USD Million)
Table 8 U.S. biosimulation market revenue estimates and forecast, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S Biosimulation Market Segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for Market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Type segment outlook
Fig. 11 Application segment outlook
Fig. 12 Distribution Channel segment outlook
Fig. 13 Competitive landscape
Fig. 14 U.S Biosimulation Market: Market dynamics
Fig. 15 U.S Biosimulation Market: Porter’s analysis
Fig. 16 U.S Biosimulation Market: PESTLE analysis
Fig. 17 U.S Biosimulation Market: Offering segment dashboard
Fig. 18 U.S Biosimulation Market: Offering movement share analysis
Fig. 19 Software Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 20 Molecular Modeling & Simulation Software Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 21 Clinical Trial Design Software Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 22 PK/PD Modeling and Simulation Software Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 23 Pbpk Modeling and Simulation Software Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 24 Toxicity Prediction Software Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 25 Other Software Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 26 Services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 27 Contract Services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 28 Consulting Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 29 Other (Implementation, Training, & Support) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 30 U.S Biosimulation Market: Application segment dashboard
Fig. 31 U.S Biosimulation Market: Application Movement Share Analysis
Fig. 32 Drug Discovery & Development Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 33 Disease Modeling Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 34 Other (Precision Medicine, Toxicology) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 35 U.S Biosimulation Market: Therapeutic Area Segment Dashboard
Fig. 36 U.S Biosimulation Market: Therapeutic Area Movement Share Analysis
Fig. 37 Oncology Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 38 Cardiovascular Disease Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 39 Infectious Disease Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 40 Neurological Disorders Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 41 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 42 U.S Biosimulation Market: Deployment Model Segment Dashboard
Fig. 43 U.S Biosimulation Market: Deployment Model Movement Share Analysis
Fig. 44 Cloud-based Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 45 On-premise Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 46 Hybrid Model Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 47 U.S Biosimulation Market: Pricing Model Segment Dashboard
Fig. 48 U.S Biosimulation Market: Pricing Model Movement Share Analysis
Fig. 49 License-based Model Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 50 Subscription-based Model Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 51 Service-based Model Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 52 Pay Per Use Model Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 53 U.S Biosimulation Market: End Use Segment Dashboard
Fig. 54 U.S Biosimulation Market: End Use Movement Share Analysis
Fig. 55 Life Sciences Companies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 56 Academic Research Institutions Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 57 Others (CROs/CDMOs, Regulatory Authorities) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 58 Company categorization
Fig. 59 Company Market position analysis, 2024
Fig. 60 Strategic framework